A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.

MLA

Buckner, J. C., et al. “A Phase III Study of Radiation Therapy plus Carmustine with or without Recombinant Interferon-Alpha in the Treatment of Patients with Newly Diagnosed High-Grade Glioma.” Cancer, vol. 92, no. 2, July 2001, pp. 420–33. EBSCOhost, https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co;2-3.

APA

Buckner, J. C., Schomberg, P. J., McGinnis, W. L., Cascino, T. L., Scheithauer, B. W., O’Fallon, J. R., Morton, R. F., Kuross, S. A., Mailliard, J. A., Hatfield, A. K., Cole, J. T., Steen, P. D., & Bernath, A. M. (2001). A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma. Cancer, 92(2), 420–433. https://doi.org/10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co;2-3

Chicago

Buckner, J C, P J Schomberg, W L McGinnis, T L Cascino, B W Scheithauer, J R O’Fallon, R F Morton, et al. 2001. “A Phase III Study of Radiation Therapy plus Carmustine with or without Recombinant Interferon-Alpha in the Treatment of Patients with Newly Diagnosed High-Grade Glioma.” Cancer 92 (2): 420–33. doi:10.1002/1097-0142(20010715)92:2<420::aid-cncr1338>3.0.co;2-3.